Confirm the diagnosis before comparing treatment
- Obtain the exact pathology subtype.
- Confirm stage and sites of spread.
- Ask whether molecular and PD-L1 testing is appropriate.
INTERNATIONAL PATIENT GUIDE
Lung cancer treatment options and care in China
A practical path from confirming the diagnosis to understanding treatment choices, checking source-verified medical resources in China and contacting an official international patient service.
START
Where should I start based on my situation?
Choose the closest situation. This does not diagnose you; it points to the information and records to review next.
01
What should be confirmed after diagnosis?
Treatment decisions cannot be made from the words “lung cancer” alone.
Pathology
Confirm non-small cell versus small cell lung cancer and the specific histologic subtype.
Stage and spread
Review chest and whole-body imaging, brain imaging when indicated, lymph-node assessment and symptoms.
Biomarkers
For appropriate non-small cell lung cancers, discuss molecular testing and PD-L1 with the treating team.
Fitness and priorities
Organ function, other illnesses, daily function, previous treatment and personal goals affect the available choices.
02
Main treatment options worldwide
The right sequence depends on subtype, stage, biomarkers, symptoms and previous treatment.
Surgery
For selected localized disease after staging and an assessment of whether surgery is safe and likely to help.
Radiation therapy
May be used with curative, postoperative, symptom-control or metastasis-directed intent.
Chemotherapy
Used in several stages of non-small cell and small cell lung cancer, alone or with other treatments.
Targeted therapy
Requires a relevant molecular alteration and a treatment appropriate to the stage and local approval status.
Immunotherapy
Selection can depend on histology, biomarkers, stage, previous treatment and contraindications.
Clinical trials
May study new drugs, combinations, procedures or treatment sequences. Listing does not mean eligibility.
Important: A new drug or technology is not automatically better for every patient. Ask what evidence applies to your exact diagnosis, what alternatives exist, and how side effects will be managed.
Considering a second opinion in China?Prepare the key diagnostic records before contacting a hospital.
See the record checklistContact With You03
When might a patient consider care in China?
China should be considered as one option to compare—not as an automatic replacement for safe local treatment.
Questions worth comparing
- Is the required medicine or technology approved and actually available?
- Does the hospital have an official disease-specific department or program?
- Can the hospital review records before travel?
- What care must continue after returning home?
Do not delay local care when
- There is breathing difficulty, major bleeding, severe infection or another emergency.
- The treating team says treatment has a narrow safe starting window.
- Travel would interrupt oxygen, anticoagulation, pain control or other essential support.
03A
Should I seek advice, travel to China, or stay with local care?
Use these four outcomes to decide the safest next action. An overseas option must not interrupt effective or urgent care near home.
Worth requesting an opinion
Your diagnosis, stage or biomarker result is uncertain; treatment choices differ; or you need a second review before a major decision. Start with remote record review where available.
Travel may be reasonable
A China hospital has reviewed your records, identified a specific service that may fit, confirmed current acceptance and explained timing, costs and follow-up.
Prioritise local treatment
Safe evidence-based care is available locally, travel would delay treatment, or the overseas hospital has not confirmed a meaningful additional option. A remote opinion may still help.
Do not delay
Breathing difficulty, major bleeding, severe infection, confusion, uncontrolled pain or rapid deterioration requires urgent local medical care. Do not wait for an overseas reply.
04
Source-verified hospitals and specialists in China
9 hospitals and 18 specialists have English names and official institutional evidence of a lung-cancer-related capability. This is not a ranking or personal recommendation.
Hospitals (9)
Cancer Hospital, Chinese Academy of Medical Sciences
Why it appears: An official institutional source documents a lung-cancer-related department or clinical capability.
International service: Not verified from the current official source set.
Check the official evidence for Cancer Hospital, Chinese Academy of Medical Sciences ↗Sun Yat-sen University Cancer Center
Why it appears: An official institutional source documents a lung-cancer-related department or clinical capability.
International service: Official international-patient contact information has been verified.
Check the official evidence for Sun Yat-sen University Cancer Center ↗The First Affiliated Hospital of Guangzhou Medical University
Why it appears: An official institutional source documents a lung-cancer-related department or clinical capability.
International service: Not verified from the current official source set.
Check the official evidence for The First Affiliated Hospital of Guangzhou Medical University ↗Peking University Cancer Hospital
Why it appears: An official institutional source documents a lung-cancer-related department or clinical capability.
International service: Not verified from the current official source set.
Check the official evidence for Peking University Cancer Hospital ↗West China Hospital, Sichuan University
Why it appears: An official institutional source documents a lung-cancer-related department or clinical capability.
International service: Not verified from the current official source set.
Check the official evidence for West China Hospital, Sichuan University ↗Shanghai Chest Hospital, Shanghai Jiao Tong University
Why it appears: An official institutional source documents a lung-cancer-related department or clinical capability.
International service: Not verified from the current official source set.
Check the official evidence for Shanghai Chest Hospital, Shanghai Jiao Tong University ↗Fudan University Shanghai Cancer Center
Why it appears: An official institutional source documents a lung-cancer-related department or clinical capability.
International service: Not verified from the current official source set.
Check the official evidence for Fudan University Shanghai Cancer Center ↗Shandong Cancer Hospital and Institute
Why it appears: An official institutional source documents a lung-cancer-related department or clinical capability.
International service: Not verified from the current official source set.
Check the official evidence for Shandong Cancer Hospital and Institute ↗Tianjin Medical University Cancer Institute and Hospital
Why it appears: An official institutional source documents a lung-cancer-related department or clinical capability.
International service: Not verified from the current official source set.
Check the official evidence for Tianjin Medical University Cancer Institute and Hospital ↗Specialists (18)
He Jie
Verified profile: The official institutional profile confirms a current role and lung-cancer-related clinical focus.
Current schedule, supported languages and international-patient acceptance are not verified.
Check the official profile for He Jie ↗Zhang Li
Verified profile: The official institutional profile confirms a current role and lung-cancer-related clinical focus.
Current schedule, supported languages and international-patient acceptance are not verified.
Check the official profile for Zhang Li ↗He Jianxing
Verified profile: The official institutional profile confirms a current role and lung-cancer-related clinical focus.
Current schedule, supported languages and international-patient acceptance are not verified.
Check the official profile for He Jianxing ↗Wang Jie
Verified profile: The official institutional profile confirms a current role and lung-cancer-related clinical focus.
Current schedule, supported languages and international-patient acceptance are not verified.
Check the official profile for Wang Jie ↗Wang Luhua
Verified profile: The official institutional profile confirms a current role and lung-cancer-related clinical focus.
Current schedule, supported languages and international-patient acceptance are not verified.
Check the official profile for Wang Luhua ↗Shi Yuankai
Verified profile: The official institutional profile confirms a current role and lung-cancer-related clinical focus.
Current schedule, supported languages and international-patient acceptance are not verified.
Check the official profile for Shi Yuankai ↗Bi Nan
Verified profile: The official institutional profile confirms a current role and lung-cancer-related clinical focus.
Current schedule, supported languages and international-patient acceptance are not verified.
Check the official profile for Bi Nan ↗Duan Jianchun
Verified profile: The official institutional profile confirms a current role and lung-cancer-related clinical focus.
Current schedule, supported languages and international-patient acceptance are not verified.
Check the official profile for Duan Jianchun ↗Wang Ziping
Verified profile: An official institutional profile or team page documents a lung-cancer-related role.
Individual schedule, supported languages and international-patient acceptance are not verified.
Check the official profile or team page for Wang Ziping ↗Zhao Jun
Verified profile: An official institutional profile or team page documents a lung-cancer-related role.
Individual schedule, supported languages and international-patient acceptance are not verified.
Check the official profile or team page for Zhao Jun ↗An Tongtong
Verified profile: An official institutional profile or team page documents a lung-cancer-related role.
Individual schedule, supported languages and international-patient acceptance are not verified.
Check the official profile or team page for An Tongtong ↗Wang Yuyan
Verified profile: An official institutional profile or team page documents a lung-cancer-related role.
Individual schedule, supported languages and international-patient acceptance are not verified.
Check the official profile or team page for Wang Yuyan ↗Zhuo Minglei
Verified profile: An official institutional profile or team page documents a lung-cancer-related role.
Individual schedule, supported languages and international-patient acceptance are not verified.
Check the official profile or team page for Zhuo Minglei ↗Li Jianjie
Verified profile: An official institutional profile or team page documents a lung-cancer-related role.
Individual schedule, supported languages and international-patient acceptance are not verified.
Check the official profile or team page for Li Jianjie ↗Jia Bo
Verified profile: An official institutional profile or team page documents a lung-cancer-related role.
Individual schedule, supported languages and international-patient acceptance are not verified.
Check the official profile or team page for Jia Bo ↗Chen Hanxiao
Verified profile: An official institutional profile or team page documents a lung-cancer-related role.
Individual schedule, supported languages and international-patient acceptance are not verified.
Check the official profile or team page for Chen Hanxiao ↗Yang Xue
Verified profile: An official institutional profile or team page documents a lung-cancer-related role.
Individual schedule, supported languages and international-patient acceptance are not verified.
Check the official profile or team page for Yang Xue ↗Chen Haiquan
Verified profile: An official institutional profile or team page documents a lung-cancer-related role.
Individual schedule, supported languages and international-patient acceptance are not verified.
Check the official profile or team page for Chen Haiquan ↗Found a potentially relevant hospital or specialist?Verify international service and current acceptance before making travel arrangements.
Ask With You to coordinateExplore 100 government-listed hospitals (not lung-cancer verified)
+
Broader national hospital directory (100)
All institutions below appear in an official government or health-authority source. This does not prove lung-cancer expertise, international-patient service or suitability for an individual.
100 institutions
北京
北京医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verified北京
北京协和医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verified北京
中日友好医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verified北京
中国医学科学院阜外医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verified北京
中国医学科学院肿瘤医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verified北京
北京大学第一医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verified北京
北京大学人民医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verified北京
北京大学第三医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verified北京
北京大学口腔医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verified北京
北京大学肿瘤医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verified北京
北京大学第六医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verified待医院官方核验
吉林大学第一医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verified上海
复旦大学附属中山医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verified上海
复旦大学附属华山医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verified上海
复旦大学附属儿科医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verified上海
复旦大学附属妇产科医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verified上海
复旦大学附属眼耳鼻喉科医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verified上海
复旦大学附属肿瘤医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verified待医院官方核验
山东大学齐鲁医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verified北京
华中科技大学同济医学院附属协和医院
综合或专科医院
2022年国家区域医疗中心输出医院名单
Lung-cancer capability and international service: not yet verifiedOfficial discovery source: 国家发展改革委、国家卫生健康委、国家中医药局 — 有序扩大国家区域医疗中心建设工作方案及输出医院名单 ↗ · checked 2026-08-02. Kept separate from the source-verified lung-cancer list above.
05
Find clinical trials with locations in China
42 registry records in the current lung-cancer dataset include at least one location in China. Filter by gene, registry status, phase or keyword. A match does not mean that a patient is eligible.
32 matching registry records with a location in China
NCT06956001 · RECRUITING · updated 2026-08-13
Check eligibility and contacts on ClinicalTrials.gov ↗Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q Mutation
PHASE3 · EGFR; NSCLC (Advanced Non-small Cell Lung Cancer)
Ethics Committee of cancer hospital, Chinese Academy of Medical Sciences, Beijing; Shandong Tumor Hospital, Shandong
NCT05276726 · RECRUITING · updated 2026-08-13
Check eligibility and contacts on ClinicalTrials.gov ↗A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1
PHASE1 / PHASE2 · Non-small Cell Lung Cancer
Research site08, Beijing; Research site09, Beijing; Research site021, Beijing
NCT07251582 · RECRUITING · updated 2026-08-13
Check eligibility and contacts on ClinicalTrials.gov ↗Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer
PHASE3 · Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC)
Hunna Cancer Hospital, Clinical Trails Center, Changsha; Hunan Cancer hospital, Changsha
NCT06416410 · RECRUITING · updated 2026-08-13
Check eligibility and contacts on ClinicalTrials.gov ↗JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C Mutation
PHASE3 · Advanced Non-squamous Non-small-cell Lung Cancer; Metastatic Non-squamous Non Small Cell Lung Cancer
Anhui Province cancer hospital, Hefei; Pecking Union Medical College Hospital, Beijing; Cancer Hospital Chinese Academy Of Medical Sciences, Beijing
NCT07593248 · RECRUITING · updated 2026-08-13
Check eligibility and contacts on ClinicalTrials.gov ↗Real-World Outcomes of Resected EGFR-Mutated NSCLC Patients Treated With Adjuvant EGFR-TKI in China
Phase not stated · Lung Cancer
Research Site, Beijing; Research Site, Chengdu; Research Site, Fuzhou
NCT06955988 · RECRUITING · updated 2026-08-13
Check eligibility and contacts on ClinicalTrials.gov ↗A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AST2303 Tablets (ABK3376 Tablets) in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
PHASE1 · Locally Advanced or Metastatic Non-small Cell Lung Cancer
Shanghai Chest Hospital, Shanghai
NCT05288205 · RECRUITING · updated 2026-08-13
Check eligibility and contacts on ClinicalTrials.gov ↗Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation
PHASE1 / PHASE2 · KRAS P.G12C; Non-small Cell Lung Cancer; Colorectal Cancer
The First Affiliated Hospital of USTC Anhui Provincial Hospital, Hefei; Pecking Union Medical College Hospital, Beijing; Cancer Hospital Chinese Academy Of Medical Sciences, Beijing
NCT07431827 · RECRUITING · updated 2026-08-13
Check eligibility and contacts on ClinicalTrials.gov ↗MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)
PHASE3 · Non-small Cell Lung Cancer
Peking University People's Hospital ( Site 2100), Beijing; Beijing Cancer hospital ( Site 2106), Beijing; Peking Union Medical College Hospital ( Site 2105), Beijing
Data source: ClinicalTrials.gov. Site data last synchronized 2026-08-14; recruitment status, full eligibility and study contacts must be rechecked on the official record.
Want to ask about a trial?Open the registry record first, then ask the listed study center to confirm status and eligibility.
Prepare your informationContact With You06
Prepare before asking for a second opinion
A complete, dated record package helps a hospital understand the question and identify missing information.
- Pathology report and, when available, pathology slides or tissue-block information
- CT, PET-CT, brain MRI and other imaging reports, plus image files in DICOM format
- Stage, molecular and biomarker reports, including the original laboratory report
- A dated treatment summary: operations, radiotherapy, medicines, doses, response and adverse effects
- Current medicines, allergies, major illnesses, recent blood tests and organ-function results
07
Before travelling to China: complete these checks
Do not buy tickets or interrupt local treatment until the receiving hospital confirms the next step through an official channel.
Ask whether the hospital accepts pathology, imaging and treatment records before travel, which file formats it accepts, and whether secure upload is available.
Open the record checklistAsk what question the hospital can answer remotely, who reviews the case, whether an in-person reassessment is required, and when to follow up if no reply arrives.
Request the consultation fee, likely assessment costs, deposit rules, accepted payment methods and what is excluded. A preliminary range is not a treatment guarantee.
Confirm required invitation or appointment documents with the hospital and current visa rules with official authorities. Do not delay urgent local treatment for travel paperwork.
Confirm the language used for consent, interpretation availability, caregiver requirements and whether translated records need certification.
Ask for a discharge summary, medicine list, monitoring schedule, emergency warning signs and a plan that can be shared with the treating team at home.
Ready to make an official inquiry?Use the verified hospital contact below and ask these six questions in writing.
Contact With YouAsk With You to help coordinate a hospital inquiry
One service entry for your next step
Tell us the diagnosis, current country, preferred language and what you want the receiving hospital to answer. With You can help organise the inquiry and identify the official hospital pathway; listing a hospital or specialist does not mean acceptance or guarantee a result.
Contact With You →Sources and review status
Hospital and specialist relationships use official institutional pages. Trial records use ClinicalTrials.gov. The medical explanation remains excluded from indexing until named medical and English-language reviewers approve this exact version.
- NCI: Non-Small Cell Lung Cancer Treatment (Patient Version)
- NCI: Small Cell Lung Cancer Treatment (Patient Version)
- NCI: Types of Cancer Treatment
Editorial source check and last resource verification: 25 August 2026. Emergency symptoms require local emergency care; do not wait for an overseas reply.